Obesity medicine specialists focus on treating obesity as a complex, chronic disease that significantly intersects with endocrine disorders such as type 2 diabetes, hypothyroidism, and polycystic ovary syndrome. Their approach involves evaluating metabolic rate, hormonal drivers of appetite, body composition, and insulin sensitivity to construct comprehensive weight management plans. These specialists recognize that weight loss requires more than calorie control—it requires addressing biological, behavioral, and pharmacologic factors.
Using tools like anti-obesity medications, metabolic assessments, and behavioral therapies, obesity medicine specialists guide patients through evidence-based interventions that promote sustainable change. They also play a preventative role, working with individuals at risk of diabetes or cardiovascular disease to reverse early metabolic dysfunction. In coordination with endocrinologists, they help fine-tune treatments for patients with overlapping endocrine and weight-related challenges. By shifting the focus from blame to biology, obesity medicine specialists empower patients to reclaim health outcomes and reduce long-term endocrine complications linked to excess weight.










Title : Changes in the global incidence of diabetes over a quarter century
F Buck Willis, Christian College of Medicine
Title : Vascular health with glucagon-like peptide-1 receptor agonists
Mahir Khalil Ibrahim Jallo, Thumbay University Hospital
Title : The prowess of Overripe Banana Sweetener (OBS) in enhancing nutritive values in food and ameliorating glycaemic responses in type 2 diabetes mellitus
Wan Rosli Wan Ishak, Universiti Sains Malaysia
Title : Wound care 2.0 creating a wound care culture TM
David Navazio, Gentell
Title : Association between diabetes technology use and prevalent macrovascular disease in adults with type 1 diabetes: A cross-sectional analysis
Divanshi Trivedi, London Northwest Hospital NHS Foundation Trust
Title : Beyond the prescription: Using GLP 1 science and lifestyle coaching to prevent prediabetes and support long term blood sugar control
Keith Hersey, Founder/CEO Destroying Diabetes
Title : Intensive versus standard blood pressure control in type 2 diabetes: Cardiovascular and microvascular outcomes
Muhammad Basil Raza, East Lancashire Hospitals NHS Trust
Title : Fetomaternal outcomes in gestational diabetes mellitus with and without polycystic ovary syndrome
Vinita Singh, AIIMS
Title : Effects of a structured education program on glycemic control in type 1 diabetes
Ana Paula Franco Pacheco, Estacio University of Brasília
Title : Cardiorespiratory fitness inflammatory and neurotrophic biomarkers and cognitive function in early versus longer duration type 2 diabetes mellitus
Arbind Kumar Choudhary, All India Institute of Medical Sciences